0001209191-22-047656.txt : 20220825
0001209191-22-047656.hdr.sgml : 20220825
20220825193904
ACCESSION NUMBER: 0001209191-22-047656
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220823
FILED AS OF DATE: 20220825
DATE AS OF CHANGE: 20220825
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kastenmayer James Paul
CENTRAL INDEX KEY: 0001798800
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37722
FILM NUMBER: 221199232
MAIL ADDRESS:
STREET 1: ONE MEDIMMUNE WAY
STREET 2: FLOOR ONE, AREA TWO
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aeglea BioTherapeutics, Inc.
CENTRAL INDEX KEY: 0001636282
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 464312787
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 805 LAS CIMAS PARKWAY
STREET 2: SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78746
BUSINESS PHONE: (512) 942-2935
MAIL ADDRESS:
STREET 1: 805 LAS CIMAS PARKWAY
STREET 2: SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78746
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-08-23
0
0001636282
Aeglea BioTherapeutics, Inc.
AGLE
0001798800
Kastenmayer James Paul
C/O AEGLEA BIOTHERAPEUTICS, INC.
805 LAS CIMAS PARKWAY, SUITE 100
AUSTIN
TX
78746
0
1
0
0
Interim CEO & General Counsel
Employee Stock Option (right to buy)
0.68
2022-08-23
4
A
0
130000
0.00
A
2032-08-22
Common Stock
130000
130000
D
The stock option vests and becomes exercisable in 48 equal monthly installments beginning on September 23, 2022 until such time as the option is 100% vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors, the stock option will vest as to 80% of the award by January 1, 2023, and 1/48 of the stock option will vest and become exercisable monthly thereafter until such time as the option is 100% vested.
/s/ James Kastenmayer
2022-08-25